Candriam SCA’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-57,550
| Closed | -$5.97M | – | 762 |
|
|
2017
Q2 | $5.97M | Sell |
57,550
-49,000
| -46% | -$5.08M | 0.11% | 216 |
|
|
2017
Q1 | $8.36M | Sell |
106,550
-130,000
| -55% | -$10.2M | 0.16% | 163 |
|
|
2016
Q4 | $10.6M | Buy |
236,550
+117,000
| +98% | +$5.25M | 0.24% | 111 |
|
|
2016
Q3 | $6.68M | Sell |
119,550
-60,000
| -33% | -$3.35M | 0.16% | 152 |
|
|
2016
Q2 | $8.98M | Buy |
179,550
+41,050
| +30% | +$2.05M | 0.23% | 112 |
|
|
2016
Q1 | $6.32M | Buy |
138,500
+12,500
| +10% | +$571K | 0.16% | 152 |
|
|
2015
Q4 | $7.76M | Buy |
126,000
+37,800
| +43% | +$2.33M | 0.21% | 127 |
|
|
2015
Q3 | $4.91M | Buy |
88,200
+16,200
| +23% | +$902K | 0.12% | 208 |
|
|
2015
Q2 | $4.39M | Sell |
72,000
-8,000
| -10% | -$488K | 0.09% | 257 |
|
|
2015
Q1 | $4.62M | Buy |
80,000
+8,000
| +11% | +$462K | 0.09% | 268 |
|
|
2014
Q4 | $4.15M | Buy |
+72,000
| New | +$4.15M | 0.09% | 265 |
|